World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management
William Shomali(Stanford Medicine), Jason Gotlib(Stanford University)
Cited by 86
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
|Haematologica|2015|252
World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management
|American Journal of Hematology|2019|191
World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management
|American Journal of Hematology|2021|172